GlassScriptPhysician profile
William David Po
NPI 1609832898
$3,494.60
in general payments reported to CMS, 2019-2025
23 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $401 · 2021: $1,437 · 2022: $188 · 2023: $408 · 2024: $414 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $1,451.97 | 2021-2025 | Nexplanon, Jada System |
| Abbvie INC. | $364.21 | 2019-2022 | |
| Hologic Sales and Service, LLC | $290.07 | 2022-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Baxter Healthcare | $193.99 | 2024-2025 | Perclot, Seprafilm |
| Minerva Surgical, INC | $170.68 | 2023-2024 | |
| Coopersurgical, INC. | $142.75 | 2020 | |
| Conmed Corporation | $124.28 | 2023 | Airseal |
| Si-Bone, INC. | $123.90 | 2019 | |
| Davol INC. | $106.39 | 2020 | |
| Amag Pharmaceuticals, INC. | $102.45 | 2019 | |
| Boston Scientific Corporation | $73.48 | 2020 | |
| Alexion Pharmaceuticals, INC. | $59.62 | 2023 | Ultomiris |
| Kci USA, INC. | $49.57 | 2020 | |
| Convatec INC. | $47.70 | 2019 | |
| Axonics, INC. | $34.01 | 2023-2024 | Bulkamid |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $29.57 | 2025 | |
| Meditrina | $29.14 | 2025 | |
| Innovation Technologies INC | $27.66 | 2025 | Irrisept |
| Medtronic, INC. | $26.97 | 2024 | Interstim |
| Evofem Biosciences, INC. | $17.49 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.78 | 2023 | |
| Merck Sharp & Dohme LLC | $12.92 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Po listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.